{
    "title": "Shares in drugmaker Shire slide after US regulator refuses to approve the Irish firm's key dry eye treatment, asks for further data",
    "url": "https://www.dailymail.co.uk/money/markets/article-3278996/Shire-shares-slide-regulator-refuses-approve-dry-eye-drug.html",
    "date": "2015-10-19",
    "keywords": [
        "shire",
        "drug",
        "cent",
        "eye",
        "lifitegrast",
        "health",
        "disease",
        "medicine",
        "decision",
        "friday",
        "bid",
        "market",
        "baxalta",
        "morning",
        "approval",
        "company",
        "week",
        "fda",
        "information",
        "quality",
        "study",
        "year",
        "regulator",
        "launch",
        "target",
        "share",
        "specialist",
        "drugmaker",
        "food",
        "administration",
        "clinical",
        "phase",
        "iii",
        "trial",
        "work",
        "executive",
        "ornskov",
        "need",
        "treatment",
        "decade",
        "submission",
        "quarter",
        "track",
        "syndrome",
        "vision",
        "itching",
        "sensation",
        "healthcare",
        "offer",
        "report",
        "doctor",
        "group",
        "rival",
        "actelion",
        "article",
        "news",
        "blow",
        "giant",
        "seller",
        "future",
        "driver",
        "producer",
        "world",
        "response",
        "letter",
        "setback",
        "developer",
        "marketing",
        "application",
        "continue",
        "prescription",
        "restasis",
        "efficacy",
        "bar",
        "trading",
        "ftse",
        "index",
        "stock",
        "uncertainty",
        "wider",
        "rout",
        "investor",
        "priceshowever",
        "speculation",
        "attention",
        "radius",
        "value",
        "back",
        "talk",
        "fall",
        "disappointment",
        "chip",
        "peer",
        "astrazeneca",
        "today"
    ],
    "category": [
        "money",
        "markets"
    ]
}